Pubblicazione "Incorporating atezolizumab in the adjuvant setting of 2 non-small cell lung cancer (NSCLC): key discussion points from an 3 expert multidisciplinary panel by Italian Association of Thoracic Oncology - AIOT"

29 Giugno

Opinion Article FRONTIERS

File Allegati

Excel, Word, PowerPoint, Pdf
Diventa socio AIOT, entra e compila il form di registrazione.
alt text